Short Summary
POSCO Co., Ltd. successfully petitioned the PTAB to institute an IPR against ArcelorMittal's patent, demonstrating a reasonable likelihood of prevailing on all 25 challenged claims. The Board found sufficient evidence across multiple grounds of obviousness (103) involving various prior art combinations.
Detailed Summary
POSCO Co., Ltd. successfully convinced the Patent Trial and Appeal Board to institute an Inter Partes Review against ArcelorMittal's patent (No. 11326227). The petitioner asserted multiple grounds of obviousness under 35 U.S.C. § 103(a), utilizing diverse combinations of prior art references such as Takagi, Cornette, Suehiro, Laurent, Vaissiere, and GMW14400. Specifically regarding the hot stamping process and multi-layered coating structure, the Board accepted that the petitioner sufficiently demonstrated a reasonable likelihood that the claimed limitations were taught or suggested by the cited references, leading to the institution of the review on all 25 claims at issue.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in POSCO Co., Ltd. et al. vs ArcelorMittal is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Medtronic, Inc.vsMoskowitz Family LLC
Medtronic has filed an IPR petition challenging claim 43 of U.S. Patent 9,005,293, asserting that the claim is anticipated or obvious over prior‑art spinal‑implant references. The petition highlights alleged nondisclosure of key references during prosecution and deficiencies in the patent’s written description.
M&A Ventures, LLC et al.vsAutoscribe Corporation
A petition was filed challenging Autoscribe Corporation's '621 patent, which covers tokenization methods for online payment processing. The petitioner argues that the claimed techniques are obvious over prior art references, specifically PayPal’s Express Checkout and Schlesser systems. The PTAB found sufficient grounds of obviousness (35 U.S.C. § 103) to institute the review.
Abbott Diabetes Care Inc. et al.vsDexCom, Inc.
Abbott Diabetes Care and DexCom settled their IPR dispute over U.S. Patent 9,801,541, filing a joint motion that led the PTAB to terminate the proceeding and keep the settlement agreement confidential.
TCL Industries Holdings Co., Ltd.vsMaxell, Ltd.
TCL has filed a petition for inter‑partes review of Maxell’s U.S. Pat. 10,219,020, seeking to invalidate claims covering a display apparatus controlled by a mobile terminal. The petition relies on Bennett and Nashida prior‑art references combined with POSITA knowledge to argue obviousness under 35 U.S.C. §103.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
Samsung successfully challenged Netlist’s 8,489,837 patent in an IPR, leading the PTAB to find all five asserted claims unpatentable as obvious over prior art. The Board rejected the patent owner’s constructions and upheld Samsung’s obviousness arguments.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.